Browse Category

NASDAQ:WLTH News 12 December 2025

Wealthfront IPO: WLTH Debuts on Nasdaq After $485M Raise, Rings Opening Bell, and Tests Consumer Fintech Appetite

Wealthfront IPO: WLTH Debuts on Nasdaq After $485M Raise, Rings Opening Bell, and Tests Consumer Fintech Appetite

NEW YORK, Dec. 12, 2025 — Wealthfront, one of the best-known robo-advisers in US consumer finance, is officially entering the public markets today. The Palo Alto-based company priced its initial public offering at $14 per share , raising roughly $485–$486 million and setting up a Nasdaq debut under the ticker WLTH . GlobeNewswire The listing-day milestone comes with a high-profile…
Wealthfront IPO Prices at $14, Raises $485 Million as WLTH Debuts on Nasdaq and Rings the Opening Bell

Wealthfront IPO Prices at $14, Raises $485 Million as WLTH Debuts on Nasdaq and Rings the Opening Bell

NEW YORK — Dec. 12, 2025 — Wealthfront, the digital wealth management platform best known for automated investing and high-yield cash products, has officially entered the public markets. The company priced its initial public offering at $14.00 per share, selling 34,615,384 shares—a deal size of about $485 million—and began its first day of trading on the Nasdaq Global Select Market…

Stock Market Today

  • Choice International's High P/E Reflects Strong Earnings Growth Potential
    February 4, 2026, 7:55 PM EST. Choice International Limited (NSE:CHOICEIN) trades at a high price-to-earnings (P/E) ratio of 78x, well above the Indian market average of around 23x. This elevated P/E signals strong investor expectations based on the company's impressive earnings growth: a 46% increase in earnings per share (EPS) last year and a 285% rise over three years. Compared to the broader market's projected 26% growth next year, Choice International's momentum justifies its premium valuation. Investors seem confident that the company's rapid growth will continue, supporting the current share price. However, a high P/E also brings risk if earnings falter, making it important to review the firm's financial health and balance sheet metrics before investing.
Go toTop